Objective: To evaluate the impact of formal education on hyperlipidemia on pharmacy students' dietary fat consumption and plasma cholesterol concentrations over a 3-month period.
Design: Prospective, open, nonrandomized, controlled trial.
Setting: College of pharmacy.
Participants: First professional-year (P1) and second professional-year (P2) pharmacy students.
Intervention: P2 students received 6 hours of formal education regarding cardiovascular risk factors and National Cholesterol Education Program guidelines for detection and treatment of hyperlipidemia.
Main Outcome Measures: Percentage of total caloric intake from fat and saturated fat and plasma cholesterol concentrations after 1 and 3 months.
Results: Significant differences were found between the percentage of total caloric intake from total and saturated fat for P1 and P2 students at all time points, with P1 > P2. A significant time effect was also found for percentage of total caloric intake from total and saturated fat as well as dietary cholesterol consumption for both groups, indicating no net effect of the formal educational intervention. No differences were found in average percentage of total caloric intakes from total and saturated fat between our student sample and that of a national sample of Americans of similar age from the National Health and Nutrition Examination Survey Series III (NHANES III). Female pharmacy students appeared to have lower plasma cholesterol concentrations than women of the same age group in the general American population.
Conclusion: Formal education did not alter students' percentage of total caloric intake from total and saturated fat or plasma cholesterol concentrations. Approximately 20% of pharmacy students may be eligible for more intensive diet and, perhaps, drug therapy for treatment of hypercholesterolemia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1331/154434503322452229 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Drug Development.
Alzheimers Dement
December 2024
Keck School of Medicine at University of Southern California, Los Angeles, CA, USA.
Background: ABCA1-mediated cholesterol transport is a central feature in many lipid- dependent diseases including APOE4-associated Alzheimer's disease and atherosclerosis-CVD. ABCA1 upregulation of RNA transcription by nuclear factors (LXR, RXR) have been associated with liver side-effects because of the common promotor element for ABCA1 and Fatty Acid Synthase. The ABCA1 agonist CS6253, derived from the C-terminal of apoE was designed to stabilize and enhance ABCA1 function, thereby providing a safe alternative to transcriptional upregulation.
View Article and Find Full Text PDFDementia Care Research and Psychosocial Factors.
Alzheimers Dement
December 2024
Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Background: The risk of cognitive decline in cancer survivors may be increased by platinum-based chemotherapy. Evidence indicates that physical exercise has a potential to reduce chemotherapy-related toxicity. The aim of this study was to assess effects of a 6-month aerobic-strength training on cognitive functions, metabolic flexibility, anthropometric parameters and physical fitness in testicular germ cell tumor (TGCT) survivors, treated with platinum-based chemotherapy.
View Article and Find Full Text PDFMilk and dairy products - a scoping review for Nordic Nutrition Recommendations 2023.
Food Nutr Res
December 2024
Nutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Milk and dairy products are major sources of protein, calcium, and other micronutrients. Milk and dairy products contribute with approximately half of the total intake of saturated fat in the Nordic and Baltic diets. Saturated fat is an important determinant of plasma total and low density lipoprotein (LDL)-cholesterol concentrations, and a causal relationship between high LDL-cholesterol and atherosclerotic cardiovascular disease has consistently been documented.
View Article and Find Full Text PDFDeterminants of growth differentiation factor 15 plasma levels in outpatients with peripheral arterial disease.
Ups J Med Sci
January 2025
Centre for Clinical Research, Uppsala University, Västmanland County Hospital, Västerås, Sweden.
Background: Growth differentiation factor 15 (GDF-15) is a robust prognostic biomarker in patients with cardiovascular (CV) disease, and a better understanding of its clinical determinants is desirable. We aimed to study the associations between GDF-15 levels and in outpatients with peripheral arterial disease (PAD).
Methods: An explorative cross-sectional study (Study of Atherosclerosis in Vastmanland, Västerås, Sweden) included 439 outpatients with carotid or lower extremity PAD.
Association between the C-reactive protein-triglyceride-glucose index and endometriosis: a cross-sectional study using data from the national health and nutrition examination survey, 1996-2006.
BMC Womens Health
January 2025
Physical Examination Center, Hebei General Hospital, Shijiazhuang, Hebei, China.
Background: The C-reactive protein-triglyceride glucose index (CTI) is a promising new marker for evaluating the severity of inflammation. Endometriosis (EM) is a prevalent chronic inflammatory condition influenced by estrogen, primarily affecting women of reproductive age. However, no study has demonstrated an association between the CTI and EM.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!